The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Sculpt By Science introduces a groundbreaking health program designed to help CEOs, entrepreneurs, and business leaders optimize their well-being, leading to enhanced professional success.
iPETcertum™ by Claritas, Developed with Cutting-Edge Technology for Enhancement, Automated Segmentation and Accurate Quantification in PET, PET-CT/MRI Scan